Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Short term Debt (2016 - 2025)

Historic Short term Debt for Integra Lifesciences Holdings (IART) over the last 15 years, with Q3 2025 value amounting to $38.8 million.

  • Integra Lifesciences Holdings' Short term Debt fell 9323.08% to $38.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.8 million, marking a year-over-year decrease of 9323.08%. This contributed to the annual value of $573.2 million for FY2024, which is 384446.36% up from last year.
  • Integra Lifesciences Holdings' Short term Debt amounted to $38.8 million in Q3 2025, which was down 9323.08% from $574.6 million recorded in Q2 2025.
  • Integra Lifesciences Holdings' Short term Debt's 5-year high stood at $574.6 million during Q2 2025, with a 5-year trough of $4.8 million in Q2 2023.
  • In the last 5 years, Integra Lifesciences Holdings' Short term Debt had a median value of $45.0 million in 2021 and averaged $154.2 million.
  • Per our database at Business Quant, Integra Lifesciences Holdings' Short term Debt surged by 580938.37% in 2024 and then crashed by 9323.08% in 2025.
  • Over the past 5 years, Integra Lifesciences Holdings' Short term Debt (Quarter) stood at $45.0 million in 2021, then dropped by 15.28% to $38.1 million in 2022, then crashed by 61.89% to $14.5 million in 2023, then surged by 3844.46% to $573.2 million in 2024, then crashed by 93.24% to $38.8 million in 2025.
  • Its Short term Debt was $38.8 million in Q3 2025, compared to $574.6 million in Q2 2025 and $573.9 million in Q1 2025.